CLINICAL_TRIALS
trial_result
· 2023-04-14
Clinical Trial Update: Intravenous Dexmedetomidine for Emergence Delirium in Pediatric Patient [Phase 4]
Summary
Phase 4 clinical trial update investigating intravenous dexmedetomidine for emergence delirium in pediatric patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Security Forces Hospital | Conditions: Emergence Delirium, Dexmeditomidine | Phase 4 | Status: UNKNOWN